---
title: "Incyte Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293975204.md"
description: "Incyte Corp. (INCY) shares rose 1.02% to $118.87 on Monday, marking its third consecutive day of gains and closing just 0.61% below its 52-week high. Despite the positive session, Incyte underperformed relative to competitors like Alnylam Pharmaceuticals and BioMarin Pharmaceutical. Trading volume reached 2.7 million, exceeding the 50-day average."
datetime: "2026-07-27T21:03:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293975204.md)
  - [en](https://longbridge.com/en/news/293975204.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293975204.md)
generator: "portal-rs"
---

# Incyte Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Incyte Corp. (INCY) rallied 1.02% to $118.87 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.02% to 7,413.18 and the Dow Jones Industrial Average rising 0.51% to 52,210.08.

This was the stock's third consecutive day of gains.

Incyte Corp. closed 0.61% short of its 52-week high of $119.60, which the company reached on July 17th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Alnylam Pharmaceuticals Inc. (ALNY) rose 2.44% to $278.40, Bio-Techne Corp. (TECH) rose 0.03% to $71.62, and BioMarin Pharmaceutical Inc. (BMRN) rose 1.58% to $60.27.

Trading volume (2.7 M) eclipsed its 50-day average volume of 1.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-27-26 1703ET

### Related Stocks

- [INCY.US](https://longbridge.com/en/quote/INCY.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)
- [BMRN.US](https://longbridge.com/en/quote/BMRN.US.md)

## Related News & Research

- [Incyte Stock: Is Wall Street Bullish or Bearish?](https://longbridge.com/en/news/296231523.md)
- [55,370 Shares in Incyte Corporation $INCY Bought by Summit Global Investments](https://longbridge.com/en/news/295999395.md)
- [Incyte President, Global Head of R&D Pablo J. Cagnoni sells 10,801 shares for $1.36 million](https://longbridge.com/en/news/296537435.md)
- [Plato Investment Management Ltd Takes Position in Incyte Corporation $INCY](https://longbridge.com/en/news/296206161.md)
- [Incyte President, Global Head of R&D Pablo J. Cagnoni sells 10,803 shares for $1.3 million](https://longbridge.com/en/news/295969312.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**